The Industry Mourns the Loss of Sanjiv Sam Gambhir, M.D., Ph.D.

Sanjiv Sam Gambhir, M.D., Ph.D.

July 20, 2020 — The radiology and molecular imaging fields mourn the loss of another brilliant leader. Sanjiv Sam Gambhir, M.D., Ph.D., director of the Molecular Imaging Program at Stanford and the Chairman of the Department of Radiology at Stanford University School of Medicine, has died from cancer at age 57. He is known for his work in early cancer detection and advancing molecular imaging, which is potentially vital in detecting and diagnosing metabolic diseases such as cancer, as well as neurological and cardiovascular diseases.

Gambhir received numerous awards, medals, and honors for his work in advancing Molecular Imaging, Nuclear Medicine, and early cancer detection. Some of his recent honors include the IEEE Marie Sklodowska-Curie Award, IEEE Advancing Technology for Humanity in 2019, and the Distinguished Investigator Award, 7th Annual Academy for Radiology and Biomedical Imaging in 2018. On the day his death was announced, he also received Stanford’s highest honor, the Dean’s Medal for Academic Excellence reserved for those whose scientific, medical, or humanitarian work has advanced the mission of Stanford Medicine, according to a report in Indica News.

Related Content

Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.

Getty Images

News | Prostate Cancer | September 24, 2021

Metastatic Prostate Cancer Comes in Two Forms, Which Could Guide Treatment

September 24, 2021 — Scientists have identified two subtypes of metastatic...

Owkin, a startup that deploys artificial intelligence (AI) and Federated Learning technologies to augment medical research and enable scientific discoveries, presented findings in Hepatocellular Carcinoma (HCC) with Cleveland Clinic at the 2021 European Society of Medical Oncology (ESMO) conference.

Illustration courtesy of Cleveland Clinic

News | Artificial Intelligence | September 24, 2021

Owkin and Cleveland Clinic Develop AI Model that Predicts Liver Cancer Prognosis

September 24, 2021 — Owkin, a startup that deploys...

The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report

Image courtesy of Varian

News | Radiation Therapy | September 24, 2021

Surface Guided Radiation Therapy Market Outlook

September 24, 2021 — The ...

The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center, Medical University of South Carolina Hollings Cancer Center and City of Hope Comprehensive Cancer Center secured a highly competitive Specialized Program of Research Excellence (SPORE) grant that aims to address lung cancer racial disparities through precision medicine, targeted smoking cessation programs and community outreach.

VCU Massey Cancer Center director and SPORE principal investigator Dr. Robert Winn explains how this grant will help combat racial inequities in lung cancer. Image courtesy of VCU Massey Cancer Center

News | Lung Imaging | September 23, 2021

$3M Grant Establishes Center to Combat Racial Inequities in Lung Cancer

September 23, 2021 — The National Cancer Institute announced tha

Doctors say they should be making medical decisions with patients, not insurance carriers and outline principles for noninvasive testing

News | Cardiac Imaging | September 23, 2021

Cardiovascular Imaging Organizations Denounce Test Substitution by Insurance Companies

September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by

GE has entered into an agreement to acquire BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners for a cash purchase price of $1.45 billion.

Getty Images

News | Radiology Business | September 23, 2021

GE Healthcare to Acquire BK Medical and Expand Ultrasound Portfolio

September 23, 2021 — GE has entered into an

This study shows that thanks to deep learning analysis applied to digitized pathology slides, artificial intelligence can classify patients with localized breast cancer between high risk and low risk of metastatic relapse in the next five years.

Getty Images

News | Artificial Intelligence | September 22, 2021

AI Predicts Risk of Breast Cancer Recurrence for Women

September 22, 2021 — The RACE AI study conducted by Gustave...

The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images

News | Radiation Oncology | September 21, 2021

New Research Guidelines Will Boost Interventional Oncology Research

September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatmen

HealthMyne, a pioneer in applied radiomics, announced today that peer-reviewed research recently published in the journal Cancers has demonstrated the ability of its radiomics technology to identify biomarkers that predict whether patients with lung adenocarcinoma would benefit from immunotherapy.

Semi-automatic lesion identification: (A) Manual ROI indication. In blue, it is possible to observe the axes that cross the lesion manually delineated by the radiologist on a plane of the MPR. The intensity of the lesion boundary (estimated) is represented with a red outline. (B) Additional axes can be dragged onto other orthogonal MPR views. From left to right, it is possible to observe the initial long axis outlined by the radiologist and the 2D contours on the axial, coronal and sagittal views of the lesion used as a starting point for the RPM algorithms. (C) Resulting 3D contour of the lesion (in blue).

News | Radiomics | September 21, 2021

HealthMyne’s Radiomic Technology Leveraged to Identify Biomarkers That Predict Immunotherapy Treatment Responses

September 21, 2021 — HealthMyne, a pioneer in applied radiomics, announced today that peer-reviewed ...

An illustration based on simulations by Rice University engineers shows a gadolinium ion (blue) in water (red and white), with inner-sphere water -- the water most affected by the gadolinium -- highlighted. The researchers’ models of gadolinium in water show there’s room for improvement in compounds used as contrast agents in clinical magnetic resonance imaging.

An illustration based on simulations by Rice University engineers shows a gadolinium ion (blue) in water (red and white), with inner-sphere water -- the water most affected by the gadolinium -- highlighted. The researchers’ models of gadolinium in water show there’s room for improvement in compounds used as contrast agents in clinical magnetic resonance imaging. Illustration by Arjun Valiya Parambathu

News | Magnetic Resonance Imaging (MRI) | September 20, 2021

Modern Simulations Could Improve MRIs

September 20, 2021 — ...